Evidence-Based Complementary and Alternative Medicine

Ethnopharmacological Studies for the Development of New Drugs


Publishing date
08 Dec 2017
Status
Published
Submission deadline
21 Jul 2017

1Universidade Federal do Amapá, Macapá, Brazil

2Universidad de Oriente, Santiago de Cuba, Cuba

3Universidad Nacional Autónoma de México, Ciudad de México, Mexico

4Universidade Federal de Sergipe, São Cristóvão, Brazil


Ethnopharmacological Studies for the Development of New Drugs

Description

Ethnopharmacology is an important discipline for the development of new medicines that are of extreme importance for the conservation and enhancement of the traditional use of natural products and undoubtedly is one of the main sources faster for the rational development of new medicines.

There are several examples of drugs that have been discovered from ethnopharmacologic studies. Therefore, in this context, the aim of this special issue is to present important studies carried out by researchers from all the areas that explore and dedicate themselves to the following themes, which can be presented for publication in this journal.

Potential topics include but are not limited to the following:

  • Ethnopharmacy
  • Ethnopharmacology and ethnobotanical studies
  • Ethnomedicine
  • The bioactive compounds from animals and plants
  • Pharmaceutical technology with natural products
  • Clinical application of natural products in different communities
  • Predictions and in silico studies with natural products
  • Alternative biological assay for determination of natural product activity
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.